Age-related hearing loss is the most common cause of adult auditory dysfunction. It is characterized by bilateral, progressive auditory deterioration associated with the aging process. There currently are limited options for the treatment as hearing aids or cochlear implants. To establish novel strategies for the treatment of this entity, it is crucial to elucidate the mechanisms of age-related hearing loss. Its etiology is believed to be multifactorial including both intrinsic and extrinsic factors. Oxidative damage, as seen in other aging organs systems, may play an essential role in the pathogenesis of the age-related hearing loss. Studies on animal models and human temporal bones have indicated a close relationship between degeneration of the cochlear lateral wall and hearing loss. Additional therapies that may prove beneficial in the treatment of age-related hearing loss include stem cell therapy, which we intend to review in this manuscript.
Introduction
Most multicellular organisms exhibit physiological and behavioral decline with aging. Within the auditory system, this decline is manifested as presbycusis or age-related hearing loss. Presbycusis is characterized by gradual, progressive, bilateral sensorineural hearing loss (SNHL) with associated impairment of word recognition. such as mutations, viral infections, autoimmune disorders, chronic noise exposure, degenerative processes, ototoxic drugs, and aging [3] [12] . The aging process associates with increased DNA damage, altered gene expression and protein function, disruption of cell matrix and organelles, disrupted metabolism, and oxidative stress [13] . Among these, oxidative stress is perhaps the most fundamental cause of age-related pathology in the biological aging of cells and may be an important intrinsic factor in presbycusis. Oxidative stress is caused by accumulation of mitochondrial DNA mutations and/or deletions (or reduced mitochondrial DNA gene expression), leading to a mitochondrial dysfunction in maintain the homeostatic level of free radicals [9] [14] . Falah et al. found a total of 113 sequence variants in mitochondrial DNA in 100% of their presbycusis patients and supported the idea of the role of mitochondria in the intracellular mechanism underlying presbycusis development. Moreover, these variants may act as potential diagnostic markers for individuals at a high risk of developing presbycusis [15] .
Principally implicated as a mediator of oxidative stress, inflammatory and infection-related damage in the central nervous system (CNS) and other tissues, is the presence of increased concentrations of free radicals such as reactive oxygen species (ROS) and reactive nitrogen species (RNS). ROS is comprised of superoxide free-radicals, hydrogen peroxides, and hydroxyl radicals. The main contributor to RNS is the gaseous transmitter nitric oxide (NO). NO and its oxidation product, such as peroxynitrite, has been shown to be a potent cellular mutagens and cytotoxic agents which may cause accumulated damage to normal cells [15] [16] . The increased release of NO may cause pathological conditions of the stria vascularis. ROS may contribute to presbycusis by damaging metabolically active tissues in the inner ear (e.g. stria vascularis), but also be involved in the accumulation of free radicals, damaging the mitochondrial DNA, and inactivating regulatory proteins by ROS and apoptosis.
We have observed inducible nitric oxide synthase (iNOS) immune-reactivity in the stria vascularis of aged animals while no iNOS expression was detected in young rats [17] . We also cultured marginal cells of the stria vascularis and exposed to NO by treating with the NO donor, sodium nitroprusside (SNP), and an elevation of intracellular calcium was observed. This may be related to the NO induced cellular apoptosis reported in other cells [17] .
Another aspect of the aging process can be represented by decreased ability of the body to defend itself against environmental insults. Inner ear and its associated structures sustain damage throughout life like any part of the human body. Thus, it is important to have effective defense mechanisms against those damages. Heat shock proteins (HSPs) are a major component of the defensive mechanisms. HSPs are stress proteins that are involved in protecting cells from a variety of stress by binding to denatured proteins and assisting in proper folding.
It has been reported that oxidative stress can induce the expression of HSPs, and HSP pre-treatment increases the protection of cells from subjacent oxidative [10] . Cigarette smoking have been associated with an increased odds ratio for the development of ARHL [24] .
High ethanol consumption has been associated with a slightly increased likelihood of the development of ARHL [25] . Stress hormones have been reported to have local and systemic effects on hearing by exerting significant effects on the delicate homeostatic mechanism of inner ear fluid and function of the inner ear.
Other late-emerging exogenous factors such as failure of the immune system, onset of autoimmune disease, or hypoxia due to vascular insufficiency may also contribute to presbycusis.
The large individual variability in the age of onset and severity of certain types of ARHL, suggest the involvement of a genetic mechanism in presbycusis. It has been suggested that strial presbycusis is likely to have a genetic etiology because of clinical impressions that the disorder is prevalent in certain families. Animal models have been developed using C57BL mice that show progressive auditory decline with age resembling certain types of hereditary hearing loss in humans [26] [27]. Thus, it is conceivable that presbycusis may be due to a genetic predisposition for the factors that are associated with sensorineural and other types of ARHL. Future research should be directed to explore basic mechanisms of the aging processes in general as well as specific functional and clinical entities.
Mechanisms of Age-Related Hearing Loss
The normal function of the inner ear occurs within specialized hair cells by converting mechanical stimuli into electrical energy. It is well established that proper control of ionic homeostasis in the inner ear fluids is essential for normal function of the inner ear. The inner ear fluids have been reported to maintain a unique composition by several mechanisms, namely, ionic pumps, constant blood supply, and blood labyrinth barriers [28] . Their data correlate with previous findings [30] of decreased endocochlear potential and endolymphatic potassium concentration with age found in gerbils.
The decreased expression of connexins with aging is observed more frequently outside the ear, such as atrophic endothelium, brain astrocytes, and gap junctions expressed by various type of cells [31] .
A study by Wu and Marcus [32] concurs with the Ichimiya study such that the spiral ligament could be among the regions responsible for cochlear malfunction with aging. The first study shows the ABR response thresholds from 6-week-old mice were significantly lower than those of 6 month or 1-year-old mice. Additionally, Sha et al. [33] observed a significant threshold shift in ABR occurring at 3 months of age at 4000 Hz without apparent hair cell loss in aged models of CBA/J mice; at 20 -26 months, threshold shifts at 12 and 24 kHz and accompanying hair cell loss at the basal turn of the cochlea; and degeneration of spiral ganglion cells by 18 months in all regions of the cochlea. Altschuler et al. [27] found moderate to large loss of outer and inner hair cell across all the cochlear turns and a significant increased ABR threshold shifts at 4, 12, 24, and 48 kHz using UM-HET4 aged mice (27 -29 months of age).
Hair Cells and Organ of Corti
Normal auditory function requires the transduction of mechanical energy (in the form of vibration of the basilar membrane and deflection of hair cell stereocilia) into electrical energy (change in the hair cell membrane potentials leading to neurotransmitter release and propagation of an action potential) in order to 
Nerves in the Auditory System
The electrical signaling to and from the brain is affected by aging [13] . The impairment in this electrical signaling may cause morphological changes in the auditory brainstem, especially in the cochlear nucleus [63] . 
The Use of Stem Cells
A successful treatment of severe to profound SNHL can be achieved by using hearing aids or other implantable devices, such as cochlear implants, and depends on activation of auditory nerve [66] . However, some patients are not suitable for these treatments, due to the complex pathogenesis of the hearing loss Hair cell differentiation is controlled by the transcription factor atonal 1 (Atoh1). Additionally, the transcription factors POU4F3 and GFI1 are also necessary to maintain the hair cell phenotype [23] . The activation of these transcription factors may therefore be key for differentiation of stem cells to become hair cells.
Sources of Stem Cells
Endogenous inner ear stem cells discovered in human fetal cochlea preserve the expression of stem cell markers, such as Nestin, Sox2, Oct4 and Rex1, and can used to generate cochlear hair cells. Under special culture conditions, these stem cells present spiral ganglion neurons and cochlear hair cells characteristics. They also express neuronal differentiation markers (Neurogen 1, Brn3a, b-tubulin III and neurofilament 200) [3] . Hair cell-like cells with mechano-sensitive functioning cilia can be generated from embryonal stem cells and inducible pluripotent stem cells [45] .
Embryonic stem cells can differentiate into inner ear progenitors and express inner hair cell phenotype. Embryogenic stem cell-derived neural progenitors can also generate cochlear hair cells and spiral ganglion neurons when manipulated in vitro. Ulfendahl et al. [69] showed a greater capacity of embryonic stem cells to survive in the inner ear. Ronaghi et al. [70] observed that differentiation of embryonic stem cells was dependent on fibroblast growth factor signaling and Atoh1 enhancer; Han et al. [71] demonstrated that embryonic stem cells implanted through cochleostomy survived in the endolymphatic space of the cochlea, and some of the surviving cells differentiated into hair cells by Atoh1 gene transfer.
Furthermore, Hildebrand et al. [72] observed the injected embryonic stem cells near the spiral ligament and stria vascularis-some cases, cells were observed close to the damaged organ of Corti structure-and Hu et al. [73] observed that embryonic dorsal root ganglion neurons had migrated along the in- [74] found transplanted dorsal root ganglion neurons survived in the scala tympani for a postoperative period ranging from 3 to 10 weeks. Coleman et al. [75] directly delivered mouse embryonic stem cells into the deafened guinea pig cochlea through a xenograft transplantation and observed a small number of viable cells in the scala tympani for up to 4 weeks following transplantation. Corrales et al. [76] injected, through a round window approach, EYFP-expressing embryonic stem cell, and observed (64 -98 days after injection) a significant increase in neuronal processes near the sensory epithelium. Recently, Chen et al. [77] reported the restoration of auditory evoked responses using embryonic stem cell derived otic progenitors. Although embryonic stem cells (ESCs) have been isolated from humans, their use in research as well as therapeutics is encumbered by ethical considerations [78] , and the propensity of ESCs to develop into teratomas [79] .
Hematopoietic stem cells obtained from chinchilla bone marrow stroma showed increased neuron and glial cell marker expression under specialized conditions. Some authors also achieved the differentiation of bone-marrow-derived CD113+ stem cells into hair cells-like using growth factors and forcing expression of transcription factor Atoh 1. A study conducted by Revoltella et al. [80] transplanted CD133+ hematopoietic stem cells into deafened mice (made by ototoxic treatment with kanamycin and/or intense noise) and observed a repairing process and stimulation ex novo of morphological recovery in the inner ear.
Elbana et al. [81] mobilized endogenous bone marrow derived stem cells using granulocyte colony stimulating factor (G-CSF) to repair experimentally damaged inner ear hair cells by amikacin injection. Their results were improvement in 50% of the sensorineural distortion product otoacoustic emission (DPOAE).
In addition, the histological examination showed recovery of the organ of Corti.
Lang et al. [82] found transplanted bone marrow stem cells −3 to 20 months after transplantation-within the spiral ligament, and some cells expressed immunoreactivity Na-K-ATPase, or to the Na-K-Cl transporter.
Mesenchymal stem cells can be induced to differentiate to osteoblasts, chondroblasts, adipocytes, fibroblasts, and skeletal muscle [83] . Aside from differentiation into cells of the mesoderm, multipotent adult progenitor cellsMAPCs-can differentiate into cells with endodermal and neuroectodermal characteristics [84] [85] [86] . Their advantages include high expansion potential, genetic stability, ease of collection, ability to migrate to the injury site, and a strong immunosuppressive property that can be exploited for autologous and heterologous transplants.
Kamiya et al. [58] Neural stem cells possess little constituent cell renewal and do not regenerate following severe injury [90] but can be recruited to substitute lost neurons if successfully grafted in the inner ear [91] . Clinical applications for neural stem cells have been demonstrated in many animal studies to regenerate or recover a nerve lesion. They are more suitable in the management of spiral ganglion neurons or nerve fibers pathology [45] .
Ren et al. [92] observed that neural stem cells differentiated into neurons, migrated and engrafted to the brain after transplantation into a 10-month of age C57BL/6J mice. Iguchi et al. [93] showed histologically that after 4 weeks of transplantation, neural stem cells survived in inner ear and most transplantderived cells had differentiated into glial cells. In another study, Xu et al. [10] introduced olfactory epithelial neural stem cells in a model of noise-induced hearing loss SD rats (3-week old, weighting 200 -250 g) and observed a decrease in ABR thresholds by the 5 th day post-implantation. Similar study by Pandit et al. [94] , found lower hearing thresholds levels in a group of A/J mices injected with olfactory stem cells (into the cochlea via lateral wall cochleostomy) compared against animals that received sham injections. However, Fu et al. [95] observed no differences in the click-ABR thresholds. Their study found that neural stem cells survived in normal rat after transplantation via round window but showed no effect on auditory function.
Stem cell-derived auditory-like neurons have also been derived from a variety of sources, such as mouse embryonic stem cells, cochlear stem cells, human embryonic stem cells, and induced pluripotent stem cells [7] .
How to Insert These Therapies in the Cochlea?
The cochlea is positioned deep inside of the skull. Even though surgically accessing the cochlea through a cochleostomy or round window approaches have been widely used for cochlear implantation, this surgical process can cause disturbance of the cochlear homeostasis, resulting in residual hearing loss and vertigo. Additionally, the aforementioned techniques are also limited to accessing just the scala tympani in the basal turn of the cochlea [45] .
Interesting method proposed by Pinyon Kamiya, in 2015, [97] showed an upregulation of homing receptors CCR2, Fetoni et al. [98] introduced adipose-derived stem cells via the round window in guinea pigs (age 3 months, weight 250 -350 g) that were exposed to noise.
They measured the ABR thresholds 3 and 7 days after the surgery, with no changes in the auditory function, but observed that the adipose-derived stem cells migrated from the perilymphatic to the endolymphatic compartment. Jang et al. [83] introduced neural-induced human mesenchymal stem cells into the basal turn of the cochlea (into the scala tympani) in deafened guinea pigs (by neomycin injection) and observed an increase in the number of spiral ganglion neurons compared to their control group. Xu et al. [10] introduced olfactory epithelial neural stem cells by drilling a hole at the promontory and localizing the scala tympani; their results suggests migration of the implanted cells to spiral ganglion neurons and decreasing threshold in the ABR.
Iguchi et al. [99] injected transplant-derived cells through lateral semicircular canal and cochlear lateral wall. After 2 weeks, showed elevation of ABR thresholds by less than 10 dB SPL in the lateral semicircular canal injection groupwhile the cochlear lateral wall injection resulted in considerable hearing loss. In a recent multinational study, named NANOCI, researchers tried to create a gapless interface between auditory nerve fibers and cochlear implant. They generated a modified nano-cochlear implant electrode array that was inserted into the scala tympani and resulted in a neurotrophin-induced attraction of neurites, which led to lower stimulation thresholds and reduction in required stimulation energy [100] .
Conclusions
Age-related hearing loss is a common condition with possible significant public Although there is no currently widely accepted treatment or preventive measure for ARHL, a number of treatments have shown promise in the literature, and the stem cells therapy seems to be a viable option for the near future.
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